This inventor holds 1 USPTO granted patent. Top assignee: Santen Pharmaceutical Co., Ltd.. Active years: 1976.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1976
Title: Shigeru Yamabe - Innovator in Metabolic Disorder Treatments
Introduction
Shigeru Yamabe is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of metabolic disorders. His innovative work has led to the development of compounds that are useful for prophylaxis and therapy in various health conditions.
Latest Patents
Yamabe holds a patent for N-(mercaptoacyl)aminoacids, which are compounds beneficial in treating metabolic disorders such as nosotoxicosis due to heavy metal radiation disorder, diabetes, or hepatitis. This patent highlights his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Throughout his career, Shigeru Yamabe has been associated with Santen Pharmaceutical Co., Ltd., where he has contributed to various research initiatives. His work has been instrumental in developing therapeutic solutions that address critical health issues.
Collaborations
Yamabe has collaborated with esteemed colleagues, including Itaru Mita and Shigeo Okumura. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Shigeru Yamabe's contributions to the field of medicine through his patents and collaborations underscore his role as a key innovator in the treatment of metabolic disorders. His work continues to impact the healthcare industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile